Aurinia Pharmaceuticals (AUPH) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Aurinia Pharmaceuticals Inc (AUPH) Prix de l'Action, Cotation, Actualités et Historique

AUPHNASDAQ

Trade with Public

Trade with Public

$16.96

0.221.31%

Dern. MÀJ: Oct 21, 12:58 PM

$16.85

0.110.66%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

$16.73

Clôture

-

Volume / Moy.

394.39K / 966.27K

Fourchette Journalière

$16.64 - $17.01

Plage 52 Sem.

11.39 - 19.25

Capitalisation Boursière

$2.26B

Ratio P/E

7.34

Rendement des Dividendes

-

Échange

NASDAQ

RSI

57

Intérêt à Découvert

6.57%

Jours pour Couvrir

9.38

Actualités Récentes de Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug

Aurinia Pharmaceuticals shares rise after settling patent litigation with Teva, which can launch generic voclosporin no earlier than December 2036.

Vandana Singh

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning

Aurinia Pharmaceuticals shares are trading higher Monday after announcing a leadership transition seen as a sign of continuity and strategy.

Henry Khederian

Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets

Aurinia Pharmaceuticals shares are trading lower Thursday afternoon after the lupus-focused drugmaker posts a blowout fourth quarter and raises expectations for continued growth in 2026.

Henry Khederian

FDA Drug Chief George Tidmarsh Resigns After Allegations Of Power Misuse

FDA drug center head George Tidmarsh resigned after accusations of misusing power to harm a former business associate. He denies wrongdoing.

Vandana Singh

US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert

U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark indices were mixed in premarket.

Rishabh Mishra

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

175.24M

Flux de Trésorerie d'Investissement (TTM)

12.84M

Flux de Trésorerie de Financement (TTM)

-61.25M

Flux de Trésorerie Libre (TTM)

175.07M

Dépenses en Capital (TTM)

-176.00K

Variation Nette de la Trésorerie (TTM)

126.83M

Tendances et prévisions des analystes

0

0

0

0

août

1

oct.

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

2.9

Conserver

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$1.85B

Ratio P/E (TTM)

7.34

Ratio P/E (FWD)

11.74

Ratio PEG (TTM)

-

Ratio P/S (TTM)

7.33

Ratio P/B (TTM)

3.62

Rendement des Bénéfices % (TTM)

13.62%

Rendement des Bénéfices % (FWD)

8.52%

EV / EBITDA (TTM)

10.06

Prix / EBITDA (TTM)

12.42

Prix / Flux de Trésorerie Libre (TTM)

13.04

Valeur Comptable / Action

$4.62

Dette Entreprise

Dette Totale

-

Dette à Long Terme

-

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-$13.99M

Trésorerie Totale

$179.83M

Dette sur Capitaux Propres

0.10

Émission de Dette (TTM)

-$13.99M

Remboursement de la Dette (TTM)

-$13.99M